Immune & thymic support sketch
Protocol overview
Immune-modulation oriented protocol sketch around Thymosin Alpha-1, Sermorelin, and NAD+.
Protocol details
Loose grouping of immune and repair-adjacent agents.
- Focus: immune modulation, thymic support, and cellular energy
- Core agents: Thymosin Alpha-1, Sermorelin, NAD+
- Note: regulatory context and indication-specific approvals differ widely by region.
Linked peptides
Peptides that appear in this protocol, with their primary perceived effect profiles.
Community tags (where this is used)
Lightweight, anonymous voting on where this protocol tends to show up in people's research (not recommendations or medical guidance).
Community stacks, dosing & cycles
Anonymous, research-framed suggestions for how people structure this protocol in practice. No medical advice; use as inspiration, then cross-check against primary evidence.
No community variants logged yet. The sample row below is illustrative until real submissions appear.
| Variant | Stack | Dosage | Cycle | Submitted | Upvotes |
|---|---|---|---|---|---|
Sample: 8-week tendon stack (example) Illustrative structure only. Replace with real-world, research-framed variants once community submissions are available. | BPC-157 + TB-500 + progressive PT 3x/week; sleep and protein focus | e.g. BPC-157 ~250 mcg daily, TB-500 twice weekly | 8–12 weeks, then reassess / deload | — | — |
Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.PubMedSermorelin
International journal of molecular sciences · 2025
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2025
Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.PubMedThymosin Alpha-1
Frontiers in cellular and infection microbiology · 2025
Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential Treatment of Pulmonary Tuberculosis: An Analysis of Immune Function, Pulmonary Function and Inflammatory Response.PubMedThymosin Alpha-1
British journal of hospital medicine (London, England : 2005) · 2025
Thymosin α1 alleviates pulpitis by inhibiting ferroptosis of dental pulp cells.PubMedThymosin Alpha-1
International journal of oral science · 2025
Single-cell analysis integrated with RNA-Sequencing uncovers new action of Patchoulol on adipose tissue remodeling in obesity.PubMedNAD+
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
Nicotinamide riboside enhances the efficacy of gemcitabine and suppresses PDAC premalignant lesions via SIRT3 activation.PubMedNAD+
Biochemical pharmacology · 2025
SMP30 May protect human lens epithelial cells against high glucose-induced oxidative damage by regulating the Keap1/Nrf2/NQO1 pathway.PubMedNAD+
Scientific reports · 2025